Blood Res.  2021 Mar;56(1):1-3. 10.5045/br.2021.2021021.

COVID-19 pandemic: a double-edged sword for cord blood banking

• Lee YH

• KMID: 2514056
• DOI: http://doi.org/10.5045/br.2021.2021021

Abstract

No abstract available

Figure

• 

  Fig. 1 Numbers of recipients and donors for stem cell transplantation before and after onset of COVID-19 (Mar. 2020) in Korea. *The data of current CB inventory are presented just until April because the donated cord bloods are registered on the national registry by “Cord Blood Act” in Korea, after 6 months of observation period for the health status of neonates. (These data are kindly provided by Korea Marrow Donor Program and Ministry of Health & Welfare of Korea). Abbreviations: BM, bone marrow; CB, cord blood; PB, mobilized peripheral blood stem cells; SCT, stem cell transplantation.

Reference

1. Algwaiz G, Aljurf M, Koh M, et al. 2020; Real-world issues and potential solutions in hematopoietic cell transplantation during the COVID-19 pandemic: perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. Biol Blood Marrow Transplant. 26:2181–9. DOI: 10.1016/j.bbmt.2020.07.021. PMID: 32717432. PMCID: PMC7380217.

2. Diriba K, Awulachew E, Getu E. 2020; The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res. 25:39. DOI: 10.1186/s40001-020-00439-w. PMID: 32887660. PMCID: PMC7471638.

3. Edlow AG, Li JZ, Collier AY, et al. 2020; Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open. 3:e2030455. DOI: 10.1001/jamanetworkopen.2020.30455. PMID: 33351086. PMCID: PMC7756241.

4. Walker KF, O'Donoghue K, Grace N, et al. 2020; Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG. 127:1324–36. DOI: 10.1111/1471-0528.16362. PMID: 32531146. PMCID: PMC7323034.

5. Huntley BJF, Huntley ES, Di Mascio D, Chen T, Berghella V, Chauhan SP. 2020; Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) infection: a systematic review. Obstet Gynecol. 136:303–12. DOI: 10.1097/AOG.0000000000004010. PMID: 32516273.

6. Yang M, Shang YX, Tian ZY, et al. 2020; Characteristics of registered studies for Coronavirus disease 2019 (COVID-19): a systematic review. Integr Med Res. 9:100426. DOI: 10.1016/j.imr.2020.100426. PMID: 32483523. PMCID: PMC7239016.

7. Malhotra A, Ernest D, Rogers BA, et al. 2020; Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trial. Trials. 21:474. DOI: 10.1186/s13063-020-04387-y. PMID: 32493459. PMCID: PMC7269684.

8. Meng F, Xu R, Wang S, et al. 2020; Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther. 5:172. DOI: 10.1038/s41392-020-00286-5. PMID: 32855385. PMCID: PMC7450163.

9. Gorman E, Shankar-Hari M, Hopkins P, et al. 2020; Repair of acute respiratory distress syndrome by stromal cell administration in COVID-19 (REALIST-COVID-19): a structured summary of a study protocol for a randomised, controlled trial. Trials. 21:462. DOI: 10.1186/s13063-020-04416-w. PMID: 32493473. PMCID: PMC7267756.

10. Stephen-Victor E, Das M, Karnam A, Pitard B, Gautier JF, Bayry J. 2020; Potential of regulatory T-cell based therapies in the management of severe COVID-19. Eur Respir J. 56:2002182. DOI: 10.1183/13993003.02182-2020. PMID: 32616599. PMCID: PMC7331657.